MIRA INFORM REPORT

 

 

Report No. :

312203

Report Date :

25.04.2015

 

IDENTIFICATION DETAILS

 

Name :

ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

 

 

Registered Office :

Ground Floor, K. J. Somaiya Hospital Campus, Off Eastern Express Highway, Sion (East), Mumbai – 400 022, Maharashtra

Tel. No.:

91-22-24066800

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

01.01.2003

 

 

Com. Reg. No.:

11-138491

 

 

Capital Investment / Paid-up Capital :

Rs.70.700 million

 

 

CIN No.:

[Company Identification No.]

U85110MH2003PTC138491

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMA22555B

 

 

PAN No.:

[Permanent Account No.]

AAECA1363P

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in providing treatment and medical relief to Cancer patients through diagnostic and treatment technologies including radiation therapy, surgery, laser surgery and gene therapy.

 

 

No. of Employees :

Information declined by the Management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The rating is constrained on account of company’s moderate financial risk profile and huge accumulated losses incurred by the company.

 

However, trade relations are fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealing with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DECLINED BY

 

Name :

Ms. Shreya

Designation :

Finance Manager

Contact No.:

91-22-24066800

Date :

24.04.2015

 

 

LOCATIONS

 

Registered Office :

Ground Floor, K. J. Somaiya Hospital Campus, Off Eastern Express Highway, Sion (East), Mumbai – 400 022, Maharashtra, India

Tel. No. :

91-22-24066800

Fax No. :

91-22-24066856

E-Mail :

info@asianoncology.com

girijagholkar12@gmail.com

dmparikh@gmail.com

p.kamble@asianoncology.com

asianinstonco@gmail.com

Website :

www.asianoncology.com

Area :

30000 sq. ft.

Location :

Rented (Owned by K.J. Somaiya Hospital)

 

 

Administrative Office :

‘D’ Block, Shiv-Sagar Estate, III Floor, Dr. Annie Besant Road, Worli, Mumbai – 400 018, Maharashtra, India

Tel. No. :

91-22-24903939

E-Mail :

asianinstonco@gmail.com

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Dr. Suresh Hariram Advani

Designation :

Director

Address :

201, 3rd Floor, Sundararn, M.G. Road, Chatkopar (East), Mumbai – 400 077, Maharashtra, India

Date of Birth/Age :

01.08.1947

Date of Appointment :

01.01.2003

DIN No.:

00134225

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH1996PLC104142

BIOMIX NETWORK LIMITED

Director

30/03/2000

30/03/2000

-

Active

NO

2

U85110MH2003PTC138491

ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

Director

01/01/2003

01/01/2003

-

Active

NO

3

U15311DL2001PTC112009

MAGIC HOSIERY PRIVATE LIMITED

Director

21/08/2003

21/08/2003

-

Active

NO

4

L99999MH1948PLC006199

FULFORD (INDIA) LIMITED

Director appointed in casual vacancy

21/07/2004

21/07/2004

28/07/2009

Active

NO

5

U91120MH2005NPL152302

ASIAN CANCER FOUNDATION

Director

31/03/2005

31/03/2005

-

Active

NO

6

U18101DL2004PTC123834

NIKUNJ GAMENTS PRIVATE LIMITED

Director

25/08/2005

25/08/2005

-

Active

NO

7

U73100DL2009PTC186274

MANTRA BIORESEARCH INDIA PRIVATE LIMITED

Additional director

18/02/2009

18/02/2009

18/08/2014

Strike off

NO

8

U93090MH2010PTC199529

ADVANI OLICKAL HEALTHCARE SERVICES PRIVATE LIMITED

Director

01/02/2010

01/02/2010

-

Active

NO

9

U74900MH2012PTC233473

SUPER SPECIALITIES PHARMA WAREHOUSING AND LOGISTICS PRIVATE LIMITED

Managing director

17/07/2012

17/07/2012

-

Active

NO

 

 

Name :

Dr. Ramakant Krishnaji Deshpande

Designation :

Director

Address :

801/802, Raheja Empress, Veer Savarkar Marg, Prabhadevi, Mumbai – 400 025, Maharashtra, India

Date of Birth/Age :

03.07.1956

Date of Appointment :

30.09.2013

DIN No.:

00374907

PAN No.:

AABPD8107E

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110MH1995PTC087043

TRIUMPH HOSPITALS PRIVATE LIMITED

Director

31/03/1995

31/03/1995

-

Active

NO

2

U24232RJ1983PLC004581

RMC MED LIMITED

Director

26/06/1996

26/06/1996

03/01/2012

Active

NO

3

U85110MH2003PTC138491

ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

Director

30/09/2013

01/01/2003

-

Active

NO

4

U70100MH1988PTC046458

TRIUMPH ESTATES PRIVATE LIMITED

Director

28/02/2005

28/02/2005

-

Active

NO

5

U91120MH2005NPL152302

ASIAN CANCER FOUNDATION

Director

30/09/2013

31/03/2005

-

Active

NO

6

U08011KA1985PLC006753

KARNATAKA LEASING AND COMMERCIAL CORPORATION LIMITED

Director

26/06/2009

07/08/2006

-

Active

NO

 

 

Name :

Dr. Jagdeesh Narhar Kulkarni

Designation :

Director

Address :

Flat No.2, 2nd Floor, Atharwa Plot No.3, Sector 3, Boulavrd Road, Hiranandani Gardens, Powai, Mumbai – 400 076, Maharashtra, India

Date of Birth/Age :

10.10.1950

Date of Appointment :

01.01.2003

DIN No.:

01297932

PAN No.:

AAKPK3649P

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110MH2003PTC138491

ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

Director

01/01/2003

01/01/2003

-

Active

NO

2

U91120MH2005NPL152302

ASIAN CANCER FOUNDATION

Director

31/03/2005

31/03/2005

-

Active

NO

 

 

Name :

Dr. Deepak Mukund Parikh

Designation :

Director

Address :

2nd Floor, Clifflet (Rear Block), 33A Sir Pochkhan Wala Road. Worli, Mumbai -  400 030, Maharashtra, India

Date of Birth/Age :

07.11.1954

Date of Appointment :

01.01.2003

DIN No.:

01297957

PAN No.:

AADPP1743L

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110MH1987PTC043669

DR M K PARIKH MEMORIAL POLYCLINIC PRIVATE LIMITED

Director

08/06/1987

08/06/1987

-

Active

NO

2

U85110MH2003PTC138491

ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

Director

01/01/2003

01/01/2003

-

Active

NO

3

U91120MH2005NPL152302

ASIAN CANCER FOUNDATION

Director

31/03/2005

31/03/2005

-

Active

NO

 

 

Name :

Dr. Gopal Ramakrishnan

Designation :

Director

Address :

Flat No.302, 3rd Floor, Vikas Apartments, Chotiram Gidwani Road, Chembur, Mumbai – 400 074, Maharashtra, India

Date of Birth/Age :

09.06.1946

Date of Appointment :

01.01.2003

DIN No.:

01298191

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85110MH2003PTC138491

ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

Director

01/01/2003

01/01/2003

-

Active

NO

2

U91120MH2005NPL152302

ASIAN CANCER FOUNDATION

Director

31/03/2005

31/03/2005

-

Active

NO

 

 

Name :

Mr. Sanjay Harishankardhar Sharma

Designation :

Director

Address :

Flat No.403-B, 4th Floor, Sagar Fortune, Plot No.184, Waterfield Road, Bandra (West), Mumbai – 400 050, Maharashtra, India

Date of Appointment :

16.03.2015

DIN No.:

07063286

 

 

KEY EXECUTIVES

 

Name :

Ms. Shreya

Designation :

Finance Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2014

 

Names of Shareholders

No. of Shares

 

Deepak M. Parikh

870000

Ramakant Deshpande

3000000

Jagannath Palepu

120000

Suresh Advani

120000

Gopal Ramkrishnan

220000

Jagdeesh N. Kulkarni

620000

Hoshi M. Bhathena

240000

Vinay Kumar Dhir

140000

Anita Maria Borges

20000

Sanjay Upadhye

120000

Dhairayasheel Savant

100000

Ulhas Kulkarni

100000

Satish Rao

100000

Dinesh Pendharkar

100000

Prince Edavazhikal

100000

Sanjay Sharma

100000

Indumati Ammbulkar

100000

Sanjay Karmarkar

100000

Vinay Deshmane

200000

Anil Bhoraskar

100000

Vinayak Jog

100000

Niliesh Lokeshwar

100000

Amish Dalal

100000

Tanveer Majeed

100000

Hemant Tongaonkar

100000

Total

7070000

 

AS ON 30.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Directors or relatives of Directors

66.92

Other top fifty shareholders

33.08

Total

100.00

 

 

                 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in providing treatment and medical relief to Cancer patients through diagnostic and treatment technologies including radiation therapy, surgery, laser surgery and gene therapy.

 

 

Products/ Services :

Item Code No. (ITC Code)

99931225

Product/ Service Description

Surgical consultation services in Oncology

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

Information declined by the Management.

 

 

Bankers :

Banker Name

Yes Bank Limited

Branch Address

Sion Branch, Mumbai, Maharashtra, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

HDFC Bank Limited

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG TERM BORROWINGS

 

 

Rupee term loans from banks

74.116

0.000

Total

74.116

0.000

 

Nature of security:

Rs.31.959 million: Secured by personal guarantee of the Directors. The loans carry rate of interest of 11.5%. The loans are repayable in equal monthly installments over a tenure of 60 months. Rs.42.158 million Secured by hypothecation of medical equipment and are personally guaranteed by Directors. The loans carry rate of interest of 11.5%. The loans are repayable in equal monthly installments over a tenure of 60 months.

 

Banking Relations :

--

 

 

Auditors :

 

Name :

ASA and Associates LLP

Chartered Accountants

Address :

68, Film Centre, C-34, 3rd Floor, J. Dadaji Road, Tardeo, Mumbai – 400 034, Maharashtra, India

PAN No.:

AAAFA4690A

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates/ Subsidiaries :

Not Available

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

10000000

Equity Shares

Rs.10/- each

Rs.100.000 million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

7070000

Equity Shares

Rs.10/- each

Rs.70.700 million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

70.700

62.400

8.400

(b) Reserves & Surplus

(50.984)

(5.455)

(6.757)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

19.716

56.945

1.643

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

74.116

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) Long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

74.116

0.000

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

19.500

0.000

0.000

(b) Trade payables

26.566

1.292

0.000

(c) Other current liabilities

47.801

0.536

0.206

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

93.867

1.828

0.206

 

 

 

 

TOTAL

187.699

58.773

1.849

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

156.412

0.111

0.133

(ii) Intangible Assets

5.709

0.000

0.000

(iii) Capital work-in-progress

0.262

18.232

0.857

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

2.248

0.007

(d)  Long-term Loan and Advances

1.794

10.721

0.006

(e) Other Non-current assets

0.000

0.000

0.431

Total Non-Current Assets

164.177

31.312

1.434

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

5.440

0.000

0.000

(c) Trade receivables

2.686

0.000

0.000

(d) Cash and cash equivalents

12.940

27.429

0.415

(e) Short-term loans and advances

2.282

0.029

0.000

(f) Other current assets

0.174

0.003

0.000

Total Current Assets

23.522

27.461

0.415

 

 

 

 

TOTAL

187.699

58.773

1.849

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from Operations

110.691

0.028

0.000

 

 

Other Income

 

 

0.030

 

 

TOTAL                                    

110.691

0.028

0.030

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Employee Benefits Expenses

0.069

 

 

Other Expenses

 

 

1.047

 

 

TOTAL                                    

153.972

(including financial and depreciation)

0.693

(including financial and depreciation)

1.116

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

 

(1.086)

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

 

 

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

 

(1.086)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION        

 

 

0.027

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

(43.281)

(0.665)

(1.113)

 

 

 

 

 

Less

TAX                                                                 

2.248

(1.967)

(0.011)

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

(45.529)

1.302

(1.102)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(5.455)

(6.757)

(5.655)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(50.984)

(5.455)

(6.757)

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(6.44)

1.52

(1.31)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

NA

NA

0.00

 

 

 

 

 

Operating Profit Margin

(PBDIT/ Sales)

(%)

NA

NA

0.00

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(23.09)

(1.74)

(112.99)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(2.20)

(0.01)

(0.68)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

4.75

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.25

15.02

2.01

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(INR in Million)

(INR in Million)

(INR in Million)

Share Capital

8.400

62.400

70.700

Reserves & Surplus

(6.757)

(5.455)

(50.984)

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

1.643

56.945

19.716

 

 

 

 

Long Term borrowings

0.000

0.000

74.116

Short Term borrowings

0.000

0.000

19.500

Total borrowings

0.000

0.000

93.616

Debt/Equity ratio

0.000

0.000

4.748

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(INR in Million)

(INR in Million)

(INR in Million)

Total Income

0.030

0.028

110.691

 

 

(6.667)

395225.000

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(INR in Million)

(INR in Million)

(INR in Million)

Total Income

0.030

0.028

110.691

Profit

(1.102)

1.302

(45.529)

 

(3673.33%)

4650.00%

(41.13%)

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

CHANGE OF ADDRESS

 

The registered office of the company has been shifted from 101, Sukh Sagar, N.S. Patkar Marg, Chowpatty, Mumbai – 400 007, Maharashtra, India to the present address w.e.f. 18.05.2013.

 

 

CORPORATE INFORMATION:

 

Subject was incorporated on 1st January 2003. Business of the Company is providing treatment and medical relief to Cancer patients through diagnostic and treatment technologies including radiation therapy, surgery, laser surgery and gene therapy.

 

 


SOMAIYA AYURVIHAR - ASIAN INSTITUTE OF ONCOLOGY AT SION

 

The company has successfully completed project of - Somaiya Ayurvihar - Asian Institute Of Oncology - at Sion on 31st August 2013.

 

Within 7 months SA-AIO has achieved turnover of Rs.109.732 million from operational activities. Pharmacy Income is Rs.26.176 million SA-AIO has treated 2044 OPD patients and 839 IPD patients.

 

YES bank has disbursed Medical loan of Rs.57.260 million out of which Rs.5.462 million has been repaid. The outstanding balance for Medical loan is Rs.51.798 million.

 

YES bank has disbursed Infrastructure loan of Rs.48.779 million out of which Rs.6.728 million has been repaid. The outstanding balance for Infrastructure loan is Rs.42.051 million.

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

SHORT TERM BORROWINGS

 

 

Loans and advances from directors

11.500

0.000

Other loans and advances

8.000

0.000

Total

19.500

0.000

 

 

INDEX OF CHARGES

 

No Charges Exist for Company.

 

 

FIXED ASSETS

 

Tangible Assets

·         Plant and Equipments

·         Furniture and Fixtures

·         Office Equipment

·         Computer Equipments

·         Leasehold Improvements

Intangible Assets

·         Computer Software

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :  No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.40

UK Pound

1

Rs.95.42

Euro

1

Rs.68.49                                                                 

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

SMN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

-- PROFITABILITY

1~10

--

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.